Velaglucerase alfa is indicated for long-term enzyme replacement therapy (ERT) for patients with type 1 Gaucher disease. Gaucher…
Strensiq or asfotase alfa is indicated for the treatment of patients with perinatal/infantile- and juvenile-onset hypophosphatasia (HPP). HPP…